VVZ-2471

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameVVZ-2471
Drug Alias NameVVZ-2471
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 antagonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsMetabotropic glutamate receptor 5Serotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsAnxietyDepressionSubstance-Related Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVivozon Inc
China Registration ClassN/A

Develop Information

Active CompaniesVivozon IncVirginia Commonwealth University
Inactive CompaniesN/A
Active IndicationsAnxietyDepressionSubstance-Related Disorders +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A